World journal of gastrointestinal pharmacology and therapeutics · 2026
Right biopsy protocol for microscopic colitis: Reduced workload and carbon footprint while maintaining diagnostic accuracy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Leung Edric, Alshareefy Yasir, Costigan Conor, Sihag Sandeep, Delaney Sarah, O'Donnell Sarah, Breslin Niall, O'Connor Anthony, Ryan Barbara, Zaheer Abdul, Cretu Ion, O'Hara Fintan, McNamara Deirdre
Аннотация
BACKGROUND: Histological findings of microscopic colitis (MC) are patchy, with potential for missed diagnoses. While guidelines recommend biopsies from the right and left sides of the colon, the optimal approach remains uncertain.
AIM: To interrogate diagnostic biopsies in a cohort of patients with confirmed MC with a view to improving biopsy protocols.
METHODS: We conducted a retrospective study of index colonoscopies in patients with MC over a 14-year period. We recorded demographics, symptoms, total number and location of biopsies, and whether they revealed features of lymphocytic or collagenous colitis.
RESULTS: A total of 228 index colonoscopies were included: 64% (145/228) lymphocytic colitis and 36% (83/228) collagenous colitis. The median age at diagnosis was 60 (interquartile range: 48-72) years, with 27% (61/228) aged < 50 years. Overall, 71% (162/228) of the patients were female, similar across subtypes. Males were older at diagnosis than females (62 vs 56, P = 0.03). Symptoms were known in 86% of patients (196/228), of whom 98% (192/196) had diarrhea. Among 150 cases with biopsies from the right colon, MC features were present in the right-colon specimens in 100%, with a patchy distribution in only 2% (3/150). In contrast, among 158 cases with biopsies from the left colon, MC features were present in the left-colon specimens in 92%. Among cases with paired right and left biopsies, 10% (13/136) had positive right-sided biopsies with negative left-sided biopsies; the converse was never observed. Regarding specimen containers, those from the left colon were more likely to be negative [9% (17/199) vs 2% (4/209), odds ratio: 4.79, P = 0.0025].
CONCLUSION: In the era of green endoscopy, our data support a protocol of taking biopsies from at least two sites in the right colon only, processed in a single container.
AIM: To interrogate diagnostic biopsies in a cohort of patients with confirmed MC with a view to improving biopsy protocols.
METHODS: We conducted a retrospective study of index colonoscopies in patients with MC over a 14-year period. We recorded demographics, symptoms, total number and location of biopsies, and whether they revealed features of lymphocytic or collagenous colitis.
RESULTS: A total of 228 index colonoscopies were included: 64% (145/228) lymphocytic colitis and 36% (83/228) collagenous colitis. The median age at diagnosis was 60 (interquartile range: 48-72) years, with 27% (61/228) aged < 50 years. Overall, 71% (162/228) of the patients were female, similar across subtypes. Males were older at diagnosis than females (62 vs 56, P = 0.03). Symptoms were known in 86% of patients (196/228), of whom 98% (192/196) had diarrhea. Among 150 cases with biopsies from the right colon, MC features were present in the right-colon specimens in 100%, with a patchy distribution in only 2% (3/150). In contrast, among 158 cases with biopsies from the left colon, MC features were present in the left-colon specimens in 92%. Among cases with paired right and left biopsies, 10% (13/136) had positive right-sided biopsies with negative left-sided biopsies; the converse was never observed. Regarding specimen containers, those from the left colon were more likely to be negative [9% (17/199) vs 2% (4/209), odds ratio: 4.79, P = 0.0025].
CONCLUSION: In the era of green endoscopy, our data support a protocol of taking biopsies from at least two sites in the right colon only, processed in a single container.